HomeAUROPHARMA • NSE
Aurobindo Pharma Ltd
₹1,161.90
Jun 6, 5:19:40 PM GMT+5:30 · INR · NSE · Disclaimer
StockIN listed securityIN headquartered
Previous close
₹1,159.50
Day range
₹1,150.00 - ₹1,174.60
Year range
₹1,010.00 - ₹1,592.00
Market cap
674.83B INR
Avg Volume
1.14M
P/E ratio
19.43
Dividend yield
-
Primary exchange
NSE
Financials
Income Statement
Revenue
Net income
(INR)Mar 2025Y/Y change
Revenue
83.82B10.58%
Operating expense
36.07B31.94%
Net income
9.03B-0.58%
Net profit margin
10.78-10.09%
Earnings per share
15.56-8.73%
EBITDA
17.60B0.79%
Effective tax rate
32.38%
Total assets
Total liabilities
(INR)Mar 2025Y/Y change
Cash and short-term investments
82.36B30.18%
Total assets
497.85B10.46%
Total liabilities
171.38B12.60%
Total equity
326.47B
Shares outstanding
580.64M
Price to book
2.06
Return on assets
Return on capital
8.40%
Net change in cash
(INR)Mar 2025Y/Y change
Net income
9.03B-0.58%
Cash from operations
Cash from investing
Cash from financing
Net change in cash
Free cash flow
About
Aurobindo Pharma Limited is an Indian multinational pharmaceutical manufacturing company headquartered in HITEC City, Hyderabad. The company manufactures generic pharmaceuticals and active pharmaceutical ingredients. The company's area of activity includes six major therapeutic and product areas: antibiotics, anti-retrovirals, cardiovascular products, central nervous system products, gastroenterologicals, and anti-allergics. The company markets these products in over 125 countries. Its marketing partners include AstraZeneca and Pfizer. Wikipedia
Founded
1986
Employees
26,015
Discover more
You may be interested in
This list is generated from recent searches, followed securities, and other activity. Learn more

All data and information is provided “as is” for personal informational purposes only, and is not intended to be financial advice nor is it for trading purposes or investment, tax, legal, accounting or other advice. Google is not an investment adviser nor is it a financial adviser and expresses no view, recommendation or opinion with respect to any of the companies included in this list or any securities issued by those companies. Please consult your broker or financial representative to verify pricing before executing any trades. Learn more
People also search for
Search
Clear search
Close search
Google apps
Main menu